Oddo BHF Asset Management Sas Invests $1.21 Million in Inspire Medical Systems, Inc. (NYSE:INSP)

Oddo BHF Asset Management Sas bought a new position in Inspire Medical Systems, Inc. (NYSE:INSP) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 5,723 shares of the company’s stock, valued at approximately $1,208,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. AQR Capital Management LLC raised its holdings in shares of Inspire Medical Systems by 152.7% during the 2nd quarter. AQR Capital Management LLC now owns 231,845 shares of the company’s stock worth $31,028,000 after acquiring an additional 140,090 shares in the last quarter. B. Metzler seel. Sohn & Co. Holding AG purchased a new stake in Inspire Medical Systems during the third quarter valued at $1,929,000. SG Americas Securities LLC lifted its position in Inspire Medical Systems by 114.2% during the second quarter. SG Americas Securities LLC now owns 6,228 shares of the company’s stock valued at $833,000 after purchasing an additional 3,321 shares during the last quarter. Thrivent Financial for Lutherans grew its stake in shares of Inspire Medical Systems by 39.7% in the 3rd quarter. Thrivent Financial for Lutherans now owns 110,580 shares of the company’s stock worth $23,337,000 after buying an additional 31,444 shares in the last quarter. Finally, Headlands Technologies LLC purchased a new position in shares of Inspire Medical Systems in the 2nd quarter worth $1,391,000. 94.91% of the stock is owned by institutional investors.

Inspire Medical Systems Stock Performance

Shares of NYSE:INSP opened at $187.96 on Friday. The firm has a market cap of $5.63 billion, a PE ratio of 175.66 and a beta of 1.31. The firm’s 50 day simple moving average is $194.30 and its 200-day simple moving average is $178.56. Inspire Medical Systems, Inc. has a one year low of $123.00 and a one year high of $257.40.

Inspire Medical Systems (NYSE:INSP) last issued its earnings results on Monday, November 4th. The company reported $0.60 earnings per share for the quarter, beating analysts’ consensus estimates of $0.06 by $0.54. Inspire Medical Systems had a return on equity of 5.30% and a net margin of 4.37%. The business had revenue of $203.20 million during the quarter, compared to analyst estimates of $197.59 million. During the same period in the previous year, the company posted ($0.29) EPS. Inspire Medical Systems’s revenue was up 32.6% on a year-over-year basis. Equities research analysts predict that Inspire Medical Systems, Inc. will post 1.33 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms recently commented on INSP. Stifel Nicolaus reiterated a “hold” rating and issued a $200.00 price target (up previously from $170.00) on shares of Inspire Medical Systems in a research report on Tuesday, November 5th. Wells Fargo & Company lifted their target price on Inspire Medical Systems from $187.00 to $198.00 and gave the stock an “equal weight” rating in a report on Tuesday, November 5th. Bank of America upgraded Inspire Medical Systems from a “neutral” rating to a “buy” rating and increased their price target for the company from $220.00 to $255.00 in a report on Wednesday, November 20th. Truist Financial reaffirmed a “buy” rating and set a $240.00 price objective (up from $217.00) on shares of Inspire Medical Systems in a research note on Monday, September 30th. Finally, Piper Sandler reissued an “overweight” rating and issued a $260.00 target price (up previously from $255.00) on shares of Inspire Medical Systems in a research note on Tuesday, November 5th. Three research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $233.58.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.